Newsroom
Biotechnology and Gene Therapy: Top gainers CLLS, WAT, ALNY, CRL, EDIT
By KlickAnalytics Data Insights | June 30, 2026 04:40PM ET
Following are the Top 5 companies based on their one-day percentage change within the 'Biotechnology and Gene Therapy' theme.
Cellectis S.A. (CLLS)
CLLS is trading UP for the last 2 days, and it at trading at $3.01 with volume of 8,947 and a one day change of $0.07 (2.38%). Cellectis S.A. has a 52-week low of 1.42 and a 52-week high of $5.48. The business's 50-day moving average price is $3.53 and its 200 day moving average price is $3.82. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 3.11.
For more information on CLLS:
Waters Corporation (WAT)
WAT is trading UP for the last 1 days, and it at trading at $375.86 with volume of 1,120,625 and a one day change of $6.99 (1.89%). Waters Corporation has a 52-week low of 275.05 and a 52-week high of $414.15. The business's 50-day moving average price is $346.03 and its 200 day moving average price is $346.84. The firm has a market cap of $22 million, a P/E ratio of 38.99, and a beta of 1.18.
For more information on WAT:
Alnylam Pharmaceuticals, Inc. (ALNY)
ALNY is trading UP for the last 2 days, and it at trading at $298.64 with volume of 728,490 and a one day change of $5.12 (1.74%). Alnylam Pharmaceuticals, Inc. has a 52-week low of 273.11 and a 52-week high of $495.55. The business's 50-day moving average price is $296.10 and its 200 day moving average price is $369.33. The firm has a market cap of $59 million, a P/E ratio of 0.00, and a beta of 0.30.
For more information on ALNY:
Charles River Laboratories International, Inc. (CRL)
CRL is trading UP for the last 6 days, and it at trading at $227.07 with volume of 602,297 and a one day change of $1.50 (0.66%). Charles River Laboratories International, Inc. has a 52-week low of 144.26 and a 52-week high of $228.88. The business's 50-day moving average price is $177.72 and its 200 day moving average price is $179.33. The firm has a market cap of $8 million, a P/E ratio of 26.81, and a beta of 1.64.
For more information on CRL:
Editas Medicine, Inc. (EDIT)
EDIT is trading UP for the last 3 days, and it at trading at $3.22 with volume of 1,228,032 and a one day change of $0.02 (0.47%). Editas Medicine, Inc. has a 52-week low of 1.66 and a 52-week high of $4.54. The business's 50-day moving average price is $2.91 and its 200 day moving average price is $2.67. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 2.42.
For more information on EDIT:
This article was generated by KlickAnalytics data insight content engine.
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with